Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shen Lu

Showing results (181-190 of 237) with videos related to

Pageof 24
Sort By:
Journal of Gastroenterology and Hepatology|May 18, 2006
Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancerHui-Ju Ch'ang, Chuan-Cheng Wang, Ann-Lii Cheng, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 10, 2009
Molecular subtypes of breast cancer emerging in young women in Taiwan: evidence for more than just westernization as a reason for the disease in AsiaChing-Hung Lin, Jau-Yu Liau, Yen-Shen Lu, et al.
Scientific Reports|January 25, 2026
Identification of candidate microRNA biomarkers of endometriosis in different bodily fluidsShiqing Lyu, Qiutong Li, Zhiyue Gu, et al.
Cancer Genetics and Cytogenetics|July 10, 2003
Recurrent genetic alterations in 26 colorectal carcinomas and 21 adenomas from Chinese patientsQiao-Jie He, Wei-Fen Zeng, Jonathan S T Sham, et al.
Future Oncology (London, England)|May 30, 2019
Neratinib after trastuzumab-based adjuvant therapy in patients from Asia with early stage HER2-positive breast cancerHiroji Iwata, Norikazu Masuda, Sung-Bae Kim, et al.
Journal of Human Genetics|January 27, 2012
Multimodel assessment of BRCA1 mutations in Taiwanese (ethnic Chinese) women with early-onset, bilateral or familial breast cancerWen-Hong Kuo, Po-Han Lin, Ai-Chu Huang, et al.
Nature Structural & Molecular Biology|January 12, 2021
A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agentTianshu Xiao, Jianming Lu, Jun Zhang, et al.
Nutrients|September 28, 2023
Lifestyle Factors and Energy Intakes with Risks of Breast Cancer among Pre- and Post- Menopausal Women in TaiwanMeng-Chuan Huang, Tz-Ting Huang, Hsin-Chun Feng, et al.
Breast Cancer Research and Treatment|June 21, 2023
Plasma cell-free tumor DNA, PIK3CA and TP53 mutations predicted inferior endocrine-based treatment outcome in endocrine receptor-positive metastatic breast cancerTom Wei-Wu Chen, Wen Hsiao, Ming-Shen Dai, et al.
BMC Cancer|January 24, 2024
A novel computer-assisted tool for 3D imaging of programmed death-ligand 1 expression in immunofluorescence-stained and optically cleared breast cancer specimensYi-Hsuan Lee, Chung-Yen Huang, Yu-Han Hsieh, et al.
Pageof 24

Showing results (181-190 of 237) with videos related to

Sort By:
Pageof 24
Journal of Gastroenterology and Hepatology|May 18, 2006
Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancerHui-Ju Ch'ang, Chuan-Cheng Wang, Ann-Lii Cheng, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 10, 2009
Molecular subtypes of breast cancer emerging in young women in Taiwan: evidence for more than just westernization as a reason for the disease in AsiaChing-Hung Lin, Jau-Yu Liau, Yen-Shen Lu, et al.
Scientific Reports|January 25, 2026
Identification of candidate microRNA biomarkers of endometriosis in different bodily fluidsShiqing Lyu, Qiutong Li, Zhiyue Gu, et al.
Cancer Genetics and Cytogenetics|July 10, 2003
Recurrent genetic alterations in 26 colorectal carcinomas and 21 adenomas from Chinese patientsQiao-Jie He, Wei-Fen Zeng, Jonathan S T Sham, et al.
Future Oncology (London, England)|May 30, 2019
Neratinib after trastuzumab-based adjuvant therapy in patients from Asia with early stage HER2-positive breast cancerHiroji Iwata, Norikazu Masuda, Sung-Bae Kim, et al.
Journal of Human Genetics|January 27, 2012
Multimodel assessment of BRCA1 mutations in Taiwanese (ethnic Chinese) women with early-onset, bilateral or familial breast cancerWen-Hong Kuo, Po-Han Lin, Ai-Chu Huang, et al.
Nature Structural & Molecular Biology|January 12, 2021
A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agentTianshu Xiao, Jianming Lu, Jun Zhang, et al.
Nutrients|September 28, 2023
Lifestyle Factors and Energy Intakes with Risks of Breast Cancer among Pre- and Post- Menopausal Women in TaiwanMeng-Chuan Huang, Tz-Ting Huang, Hsin-Chun Feng, et al.
Breast Cancer Research and Treatment|June 21, 2023
Plasma cell-free tumor DNA, PIK3CA and TP53 mutations predicted inferior endocrine-based treatment outcome in endocrine receptor-positive metastatic breast cancerTom Wei-Wu Chen, Wen Hsiao, Ming-Shen Dai, et al.
BMC Cancer|January 24, 2024
A novel computer-assisted tool for 3D imaging of programmed death-ligand 1 expression in immunofluorescence-stained and optically cleared breast cancer specimensYi-Hsuan Lee, Chung-Yen Huang, Yu-Han Hsieh, et al.
Pageof 24